Distinct prostate cancer-related mRNA cargo in extracellular vesicle subsets from prostate cell lines

BMC Cancer

Research Article

Jorge Oliver-De La Cruz¹  Pia Siljander²  Marjo Yliperttula³  Carmen Escobedo-Lucea⁴  Elisa Lázaro-Ibáñez⁵  Taral R. Lunavat⁶  Jan Lötvall⁶  Su Chul Jang⁶ 

[1] Center for Translational Medicine, International Clinical Research Center, St. Anne’s University Hospital, 65691, Brno, Czech Republic;Division of Pharmaceutical Biosciences, Centre for Drug Research, Faculty of Pharmacy, University of Helsinki, 00014, Helsinki, Finland;Division of Biochemistry and Biotechnology, Department of Biosciences, University of Helsinki, 00014, Helsinki, Finland;Division of Pharmaceutical Biosciences, Centre for Drug Research, Faculty of Pharmacy, University of Helsinki, 00014, Helsinki, Finland;Division of Pharmaceutical Sciences, Faculty of Pharmacy, University of Padova, 35131, Padova, Italy;Division of Pharmaceutical Biosciences, Centre for Drug Research, Faculty of Pharmacy, University of Helsinki, 00014, Helsinki, Finland;Institute for Advanced Biomedical Engineering, Tokyo Women´s Medical University (TWINS), 162 8666, Tokyo, Japan;Division of Pharmaceutical Biosciences, Centre for Drug Research, Faculty of Pharmacy, University of Helsinki, 00014, Helsinki, Finland;Krefting Research Center, Department of Internal Medicine and Clinical Nutrition, University of Gothenburg, 40530, Gothenburg, Sweden;Krefting Research Center, Department of Internal Medicine and Clinical Nutrition, University of Gothenburg, 40530, Gothenburg, Sweden;

关键词: mRNA;    Extracellular vesicles;    Microvesicles;    Exosomes;    Prostate cancer;   

DOI  :  10.1186/s12885-017-3087-x

 received in 2016-10-18, accepted in 2017-01-24,  发布年份 2017

来源: Springer

【 摘 要 】

BackgroundMultiple types of extracellular vesicles (EVs), including microvesicles (MVs) and exosomes (EXOs), are released by all cells constituting part of the cellular EV secretome. The bioactive cargo of EVs can be shuffled between cells and consists of lipids, metabolites, proteins, and nucleic acids, including multiple RNA species from non-coding RNAs to messenger RNAs (mRNAs). In this study, we hypothesized that the mRNA cargo of EVs could differ based on the EV cellular origin and subpopulation analyzed.MethodsWe isolated MVs and EXOs from PC-3 and LNCaP prostate cancer cells by differential centrifugation and compared them to EVs derived from the benign PNT2 prostate cells. The relative mRNA levels of 84 prostate cancer-related genes were investigated and validated using quantitative reverse transcription PCR arrays.ResultsBased on the mRNA abundance, MVs rather than EXOs were enriched in the analyzed transcripts, providing a snapshot of the tumor transcriptome. LNCaP MVs specifically contained significantly increased mRNA levels of NK3 Homeobox 1 (NKX3-1), transmembrane protease serine 2 (TMPRSS2), and tumor protein 53 (TP53) genes, whereas PC-3 MVs carried increased mRNA levels of several genes including, caveolin-2 (CAV2), glutathione S-transferase pi 1 (GSTP1), pescadillo ribosomal biogenesis factor 1 (PES1), calmodulin regulated spectrin associated protein 1 (CAMSAP1), zinc-finger protein 185 (ZNF185), and others compared to PNT2 MVs. Additionally, ETS variant 1 (ETV1) and fatty acid synthase (FASN) mRNAs identified in LNCaP- and PC-3- derived MVs highly correlated with prostate cancer progression.ConclusionsOur study provides new understandings of the variability of the mRNA cargo of MVs and EXOs from different cell lines despite same cancer origin, which is essential to better understand the the proportion of the cell transcriptome that can be detected within EVs and to evaluate their role in disease diagnosis.

【 授权许可】

CC BY   
© The Author(s). 2017